At a glance
ClinicalIndex Comparison RecordN/ACompleted· 20 enrolled
Drug / intervention
Microfocused ultrasound with visualizationdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Evaluation of the Ulthera System for Treating Axillary Hyperhidrosis
In Brief
A clinical study evaluating Microfocused ultrasound with visualization for Axillary Hyperhidrosis. Completed, enrolled 20 participants across 2 sites.
Detailed Summary
To evaluate the Ulthera System and the 7-3.0mm transducer for treating axillary hyperhidrosis.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAxillary Hyperhidrosis
CountriesGermany
Collaborators--
Timeline
N/ACompletedFinished
2017201820192020202120222023202420252026
Enrollment StartDec 2016
Primary CompletionJun 2017
Study CompletionAug 2017
First PostedOct 2017
TodayJul 2026
First PostedOct 25, 2017
Enrollment StartDec 13, 2016
Primary CompletionJun 19, 2017
Study CompletionAug 22, 2017
TodayJul 2, 2026
Enrollment to primary: 6 monthsPosted 8.7 years ago
Interventions
Microfocused ultrasound with visualizationdevice
Subjects will receive 2 treatments (day 1 and day 30), each at a 3.0mm depth and 0.30 Joule of energy. Treatment will be delivered in a 3\*4 grid, 12 treatment squares, delivering 60 lines of treatment per square, i.e., 720 lines per axilla in each treatment (1440 lines total per treatment.)